Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.2020007081
PubMed Identifier: 32750105
Publication URI: http://europepmc.org/abstract/MED/32750105
Type: Journal Article/Review
Parent Publication: Blood
Issue: 2
ISSN: 0006-4971